SCD Stock Overview
Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zentiva S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | RON2.00 |
| 52 Week High | RON2.20 |
| 52 Week Low | RON1.77 |
| Beta | 0.29 |
| 1 Month Change | -2.91% |
| 3 Month Change | -2.91% |
| 1 Year Change | 3.09% |
| 3 Year Change | -17.36% |
| 5 Year Change | -42.03% |
| Change since IPO | 3,926.58% |
Recent News & Updates
Recent updates
Zentiva's (BVB:SCD) Solid Earnings May Rest On Weak Foundations
May 24
Zentiva (BVB:SCD) Has Gifted Shareholders With A Fantastic 201% Total Return On Their Investment
Mar 01Zentiva S.A.'s (BVB:SCD) Stock Is Going Strong: Have Financials A Role To Play?
Jan 25
Zentiva S.A. (BVB:SCD) Investors Are Less Pessimistic Than Expected
Dec 18Shareholder Returns
| SCD | RO Pharmaceuticals | RO Market | |
|---|---|---|---|
| 7D | 2.6% | 0.5% | -1.4% |
| 1Y | 3.1% | -5.0% | -4.3% |
Return vs Industry: SCD exceeded the RO Pharmaceuticals industry which returned -5.2% over the past year.
Return vs Market: SCD exceeded the RO Market which returned -3% over the past year.
Price Volatility
| SCD volatility | |
|---|---|
| SCD Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 4.8% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in RO Market | 5.9% |
| 10% least volatile stocks in RO Market | 2.4% |
Stable Share Price: SCD is more volatile than 90% of RO stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: SCD's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of RO stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 852 | Simona Cocos | https://www.zentiva.ro |
Zentiva S.A. engages in the production and marketing of preparations and medicines for human use in Romania and internationally. Its product portfolio includes tablets, capsules, and pellets, as well as injectable solutions. The company was formerly known as Sicomed S.A. and changed its name to Zentiva S.A. in January 2006.
Zentiva S.A. Fundamentals Summary
| SCD fundamental statistics | |
|---|---|
| Market Cap | RON1.39b |
| Earnings (TTM) | RON90.94m |
| Revenue (TTM) | RON718.83m |
15.3x
P/E Ratio1.9x
P/S RatioIs SCD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SCD income statement (TTM) | |
|---|---|
| Revenue | RON718.83m |
| Cost of Revenue | RON357.81m |
| Gross Profit | RON361.02m |
| Other Expenses | RON270.08m |
| Earnings | RON90.94m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 50.22% |
| Net Profit Margin | 12.65% |
| Debt/Equity Ratio | 0% |
How did SCD perform over the long term?
See historical performance and comparison